Journal
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES
Volume 1462, Issue 1, Pages 14-26Publisher
WILEY
DOI: 10.1111/nyas.14235
Keywords
vaccine; vaccinology; monoclonal antibodies; RNA vaccine; DNA vaccine; infectious disease; antimicrobial resistance; maternal immunization; tuberculosis; malaria; HIV; RSV; CMV; Ebola; Zika; MERS; influenza; systems vaccinology
Categories
Funding
- Pfizer
- GSK
- Merck
- Novavax
- Serendipity Foundation
- GAVI, the Vaccine Alliance
- Human Vaccines Project
- Inflammation Research Association
- International AIDS Vaccine Initiative
Ask authors/readers for more resources
Vaccines have been incredibly successful at stemming the morbidity and mortality of infectious diseases worldwide. However, there are still no effective vaccines for many serious and potentially preventable infectious diseases. Advances in vaccine technology, including new delivery methods and adjuvants, as well as progress in systems biology and an increased understanding of the human immune system, hold the potential to address these issues. In addition, maternal immunization has opened an avenue to address infectious diseases in neonates and very young infants. This report summarizes the presentations from a 1-day symposium at the New York Academy of Sciences entitled Innovative Vaccines against Resistant Infectious Diseases and Emerging Threats, held on May 20, 2019.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
